bioAffinity (BIAF) news
Recent news
BioAffinity Technologies: 1-for-15 reverse stock split effective at open of trading on Aug 24, 2026
AInvest Wire · Aug 20, 2026BioAffinity Technologies announces closing of $4M private placement offering priced at-the-market under Nasdaq rules
AInvest Wire · Aug 14, 2026Wallachbeth Capital announces closing of BioAffinity Technologies $3.2 million offering
On June 18, 2026, WallachBeth Capital, LLC confirmed the closing of a $3.2 million public offering for bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology firm specializing in noninvasive diagnostic tools for early-stage lung cancer detection. The offering included 4,000,000…
AInvest Wire · Jun 18, 2026BioAffinity Technologies announces closing of $3.2 million offering
BioAffinity Technologies, Inc. (NASDAQ: BIAF) has announced the successful closing of a $3.25 million funding round on May 7, 2025. The offering included the issuance of over 10 million shares of common stock, accompanied by warrants to purchase additional shares at $0.32 per unit. WallachBeth…
AInvest Wire · Jun 18, 2026BioAffinity Technologies announces pricing of $3.2 million offering
BioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) announced the pricing of a public offering expected to generate approximately $3.2 million in gross proceeds before deducting agent fees and other estimated expenses. The offering includes 12,500,000 shares of common stock or pre-funded warrants,…
AInvest Wire · Jun 17, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.